To accelerate its mission of delivering life-saving treatments faster, a leading biopharma company set out to modernize its pharmacokinetics (PK), genotyping, and gene expression workflows. Faced with manual processes, fragmented systems, and compliance hurdles, the organization needed an integrated, AI-powered solution to streamline operations, ensure regulatory compliance, and support high-throughput R&D. By digitizing and unifying its bioanalytical workflows, the company is looking forward to drive efficiency, accuracy, and speed across assay analytics and genetic analysis. This transformation reflects its unwavering commitment to innovation and operational excellence throughout the drug development lifecycle.